| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $619.7M | +7.4% |
| Cost of Revenue | $409.9M | +33.4% |
| R&D Expense | $94.3M | +0.6% |
| SG&A Expense | $89.0M | +9.4% |
| Operating Income | -$155.0M | -37.4% |
| Pre-tax Income | -$157.5M | -16.2% |
| Income Tax | $1.6M | +131.0% |
| Net Income | -$159.2M | -22.1% |
| EPS (Basic) | -$1.17 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $326.2M | -0.0% |
| Accounts Receivable | $1.18B | +20.5% |
| Current Assets | $1.52B | +14.8% |
| Total Assets | $2.69B | -0.9% |
| Current Liabilities | $1.40B | +24.6% |
| Long-term Debt | $533.0M | -29.4% |
| Total Liabilities | $1.99B | +3.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $214.4M | +11.3% |
| Capital Expenditures | $26.8M | -13.1% |
| Investing Cash Flow | -$37.4M | +42.6% |
| Financing Cash Flow | -$177.8M | -489.4% |
| Free Cash Flow | $187.6M | +16.0% |
| -19.4% |
| EPS (Diluted) | -$1.17 | -19.4% |
| Stockholders' Equity |
| $701.7M |
| -11.3% |